Primary validation study of a new generation of solid phase cytometer for rapid sterility testing of pharmaceutical...

Area of Science:

• Pharmaceutical Microbiology
• Analytical Chemistry
• Biotechnology

Background:

• Sterility testing is critical for pharmaceutical product safety, especially for parenteral drugs.
• Conventional sterility testing methods have long incubation times (up to 14 days), delaying product release.
• Rapid microbiological methods are needed to improve efficiency and reduce time-to-result (TTR).

Purpose of the Study:

• To evaluate the performance of the Red One™ system as a rapid sterility testing method.
• To compare the Red One™ system against traditional culture-based sterility testing.
• To assess the non-inferiority of the Red One™ system for pharmaceutical applications.

Main Methods:

• The Red One™ system, employing solid-phase cytometry (SPC) and esterase-based activity staining, was used for rapid sterility testing.
• Performance parameters including limit of detection (LOD), accuracy, robustness, and ruggedness were evaluated.
• Testing included various microorganisms, with a focus on slow-growing species like Cutibacterium acnes.

Main Results:

• The Red One™ system demonstrated a reduced TTR of 96 hours, significantly faster than conventional methods.
• The system showed non-inferiority compared to traditional culture-based sterility testing.
• Key performance parameters confirmed the reliability and effectiveness of the Red One™ system across different microorganisms.

Conclusions:

• The Red One™ system is a viable and effective alternative for rapid sterility testing in the pharmaceutical industry.
• This method offers significant advantages in reducing TTR, thereby improving testing efficiency.
• The study supports the adoption of the Red One™ system for enhanced pharmaceutical quality control and patient safety.